P11 (S100A10) as a potential biomarker of psychiatric patients at risk of suicide

Journal of Psychiatric Research

Volumn 45, Issue 4, 2011, Pages 435-441

  Zhang, Lei ^a   Su, Tung Ping ^b   Choi, Kwang ^c   Maree, Webster ^c   Li, Cheng Ta ^b   Chung, Ming Yi ^b   Chen, Ying Sheue ^b   Bai, Ya Mei ^b   Chou, Yuan Hwa ^b   Barker, Jeffery L ^d   Barrett, James E ^e   Li, Xiao Xia ^a   Li, He ^a   Benedek, David M ^a   Ursano, Robert ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Stanley Medical Research Institute   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Major depressive disorder (MDD); P11; Post traumatic stress disorder (PTSD); Suicide; Suicide attempt

Indexed keywords

BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; MESSENGER RNA; PROTEIN P11; PROTEIN S100B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MAJOR DEPRESSION; MALE; MENTAL PATIENT; META ANALYSIS; MICROARRAY ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SUICIDE ATTEMPT;

ADULT; ANALYSIS OF VARIANCE; ANNEXIN A2; BIOLOGICAL MARKERS; DEPRESSION; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NERVE GROWTH FACTORS; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, PURINERGIC P2X7; RNA, MESSENGER; S100 PROTEINS; SUICIDE;

EID: 79952620806     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.08.012     Document Type: Article

References (23)

1. Anisman H., Du L., Palkovits M., Faludi G., Kovacs G.G., Szontagh-Kishazi P., et al. Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects. Journal of Psychiatry Neuroscience 2008, 33:131-141.
2. Bertolote J.M., Fleischmann A. Suicide and psychiatric diagnosis: a worldwide perspective. World Psychiatry 2002, 1:181-185.
3. Cavanagh J.T., Carson A.J., Sharpe M., Lawrie S.M. Psychological autopsy studies of suicide: a systematic review. Psychology Medicine Journal 2003, 33:395-405.
4. Choi K.H., Elashoff M., Higgs B.W., Song J., Kim S., Sabunciyan S., et al. Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays. BMC Psychiatry 2008, 8:87.
5. Choi K.H., Higgs B.W., Weis S., Song J., Llenos I.C., Dulay J.R., et al. Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects. BMC Psychiatry 2009, 9:57.
6. Davidson J.R., Hughes D., Blazer D.G., George L.K. Post-traumatic stress disorder in the community: an epidemiological study. Psychology Medicine Journal 1991, 21:713-721.
7. Falcone T., Fazio V., Lee C., Simon B., Franco K., Marchi N., Janigro D. Serum S100B: a potential biomarker for suicidality in adolescents?. PLoS One 2010, 5:e11089.
8. Floen S.K., Elklit A. Psychiatric diagnoses, trauma, and suicidiality. Annals of General Psychiatry 2007, 6:12.
9. Hamilton M., White J.M. Clinical syndromes in depressive states. The Journal of Mental Science 1959, 105:985-998.
10. Hawton K., van Heeringen K. Suicide. Lancet 2009, 373:1372-1381.
11. Hejjas K., Szekely A., Domotor E., Halmai Z., Balogh G., Schilling B., et al. Association between depression and the Gln460Arg polymorphism of P2RX7 gene: a dimensional approach. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 2009, 150B:295-299.
12. Henderson S., Andrews G., Hall W. Australia's mental health: an overview of the general population survey. Australian and New Zealand Journal of Psychiatry 2000, 34:197-205.
13. Kochanek K.D., Murphy S.L., Anderson R.N., Scott C. Deaths: final data for 2002. National Vital Statistics Reports 2004, 53:1-115.
14. Lecrubier Y., Clerc G., Didi R., Kieser M. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. The American Journal of Psychiatry 2002, 159:1361-1366.
15. Mann J.J. The neurobiology of suicide. Nature Medicine 1998, 4:25-30.
16. Reutfors J., Brandt L., Jonsson E.G., Ekbom A., Sparen P., Osby U. Risk factors for suicide in schizophrenia: findings from a Swedish population-based case-control study. Schizophrenia Research 2009, 108:231-237.
17. Santamaria-Kisiel L., Rintala-Dempsey A.C., Shaw G.S. Calcium-dependent and -independent interactions of the S100 protein family. The Biochemical Journal 2006, 396:201-214.
18. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 59(Suppl 20):22-33. quiz 34-57.
19. Su T.P., Zhang L., Chung M.Y., Chen Y.S., Bi Y.M., Chou Y.H., et al. Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders. Journal of Psychiatric Research 2009, 43:1078-1085.
20. Svenningsson P., Chergui K., Rachleff I., Flajolet M., Zhang X., El Yacoubi M., et al. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 2006, 311:77-80.
21. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The stanley foundation brain collection and neuropathology consortium. Schizophrenia Research 2000, 44:151-155.
22. Wonderlich S.A., Brewerton T.D., Jocic Z., Dansky B.S., Abbott D.W. Relationship of childhood sexual abuse and eating disorders. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36:1107-1115.
23. Zhang L., Li H., Su T.P., Barker J.L., Maric D., Fullerton C.S., et al. p11 is up-regulated in the forebrain of stressed rats by glucocorticoid acting via two specific glucocorticoid response elements in the p11 promoter. Neuroscience 2008, 153:1126-1134.